Literature DB >> 7803288

IgD monoclonal gammopathy with long-term follow-up.

J Bladé1, R A Kyle.   

Abstract

The presence of a serum IgD monoclonal protein (M-protein) is usually indicative of a malignant plasma cell disorder. However, one case of well-documented benign monoclonal gammopathy (BMG) of IgD type has been reported. We describe another patient with IgD monoclonal gammopathy of undetermined significance (MGUS) with long-term follow-up. In this patient an IgD lambda M-protein was found on routine serum electrophoresis. She is alive and has no evidence of multiple myeloma or amyloidosis after 8 years of follow-up. Although IgD MGUS is exceedingly rare, this case demonstrates that the presence of a serum IgD M-protein is not necessarily synonymous with a malignant plasma cell process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803288     DOI: 10.1111/j.1365-2141.1994.tb05037.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Immunoglobulin D: properties, measurement, and clinical relevance.

Authors:  A O Vladutiu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Myeloma as a model for the process of metastasis: implications for therapy.

Authors:  Irene M Ghobrial
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

3.  AL amyloidosis with IgD-lambda monoclonal gammopathy and lambda-type Bence-Jones protein: successful treatment by autologous stem cell transplantation.

Authors:  Chanhyok Sakurai-Chin; Yoshifumi Ubara; Tatsuya Suwabe; Junichi Hoshino; Tomoki Yonaha; Eiko Hasegawa; Keiichi Sumida; Rikako Hiramatsu; Masayuki Yamanouchi; Noriko Hayami; Junji Yamauchi; Naoyuki Tominaga; Naoki Sawa; Fumi Takemoto; Kazuhiro Masuoka; Kenmei Takaichi; Kenichi Oohashi
Journal:  Clin Exp Nephrol       Date:  2010-07-15       Impact factor: 2.801

4.  A monoclonal gammopathy precedes multiple myeloma in most patients.

Authors:  Brendan M Weiss; Jude Abadie; Pramvir Verma; Robin S Howard; W Michael Kuehl
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

5.  AL Amyloidosis in a Patient with IgD Myeloma.

Authors:  Hicham Rafik; Kawtar Hassani; Taoufiq Aatif; Driss El Kabbaj; Samira E Idrissi; Zohra Ouzzif
Journal:  Indian J Nephrol       Date:  2019-09-03

6.  IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy.

Authors:  Francesco Pisani; Maria Teresa Petrucci; Diana Giannarelli; Velia Bongarzoni; Marco Montanaro; Valerio De Stefano; Giacinto La Verde; Fabiana Gentilini; Anna Levi; Tommaso Za; Alessandro Moscetti; Luciana Annino; Maria Concetta Petti
Journal:  J Exp Clin Cancer Res       Date:  2012-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.